Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Vaccine    crawled date : 2021 - 07 - 29    save search

Vaxart Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine
Published: 2021-07-29 (Crawled : 21:00) - biospace.com/
VXRT | $0.8903 -2.07% -2.11% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 6.94% H: 5.92% C: -11.16%

vaccine response
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
Published: 2021-07-29 (Crawled : 20:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.35% C: -0.32%
EBS F | $1.94 -2.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 1.66% H: 2.7% C: -1.54%

covid vaccine merge covid-19
COVID News: EUA Expanded for Baricitinib, Emergent Starts to Manufacture J&J Vaccine Again and More
Published: 2021-07-29 (Crawled : 16:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.35% C: -0.32%

covid baricitinib vaccine merge
Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead wi...
Published: 2021-07-29 (Crawled : 16:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 0.08% C: -0.33%

vaccine
Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead with FDA Filing
Published: 2021-07-29 (Crawled : 15:15) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 0.08% C: -0.33%

fda vaccine
Pfizer-BioNTech Vaccine: African Deal, $34 Billion in Sales, and Efficacy Drop
Published: 2021-07-29 (Crawled : 15:00) - biospace.com/
JNJ | $144.45 -2.13% 0.03% 13M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.35% C: -0.32%

sales drop vaccine
AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinson’s Disease at AAIC 2021
Published: 2021-07-29 (Crawled : 12:00) - globenewswire.com
ACIU | $2.47 -1.98% -2.02% 170K twitter stocktwits trandingview |
Health Technology
| | O: 2.04% H: 1.06% C: -5.45%

disease phase 1 results parkinson vaccine phase 1b diagnostic phase 2b
Gainers vs Losers
58% 42%

Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M twitter stocktwits trandingview |
Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K twitter stocktwits trandingview |
Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M twitter stocktwits trandingview |
Health Technology

SXTC | $1.68 43.59% 30.36% 34M twitter stocktwits trandingview |
Health Technology

DYNT | $0.531 43.36% 30.24% 22M twitter stocktwits trandingview |
Health Technology

KA | $0.4796 41.06% 29.11% 5.3M twitter stocktwits trandingview |
Manufacturing

PALI | $5.86 40.87% 29.01% 29M twitter stocktwits trandingview |
Manufacturing

CLNN | $0.319 -3.74% 28.75% 6.3M twitter stocktwits trandingview |

BSGM | $1.52 38.18% 27.63% 3.3M twitter stocktwits trandingview |
Health Technology

MCBC | $13.67 37.66% 27.36% 2.2M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.